With
"so if they both failed to replicate the same results in phase 2"
you may be interpreted as suggesting that BTX 1503 Phase 2 failed to replicate Phase 1 results
but given BTX 1503 Phase 2 Oz results are a replica of Phase 1, in the light of the rather feeble unofficial waffle from Matt (sorry to say) as to the cause of the US results, in the light of the Italian Job, and in the light of the sell down, in my opinion the only reasonable explanation for the strange US results is a simple label swap (actual or implicit) so the actual US results would also be a replica of Phase 1.
So, in the absence of an official (and plausible!) explanation for the US BTX 1503 Phase 2 results, to my mind the swap hypothesis prevails, BTX 1503 Phase 2 replicates Phase 1, and you are not in a position to push your innuendo, so I suggest you desist.
- Forums
- ASX - By Stock
- BOT
- Know when to Holdem... Know when to run
BOT
botanix pharmaceuticals ltd
Add to My Watchlist
9.68%
!
34.0¢

Know when to Holdem... Know when to run, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
34.0¢ |
Change
0.030(9.68%) |
Mkt cap ! $666.7M |
Open | High | Low | Value | Volume |
31.0¢ | 35.0¢ | 31.0¢ | $3.702M | 11.12M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 278570 | 33.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.0¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 275585 | 0.335 |
12 | 550245 | 0.330 |
7 | 273690 | 0.325 |
8 | 303165 | 0.320 |
12 | 521002 | 0.315 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 115000 | 3 |
0.350 | 169326 | 7 |
0.355 | 173000 | 4 |
0.360 | 92950 | 7 |
0.370 | 260842 | 4 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online